TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 294 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,167,965 | -4.4% | 533,157 | -2.0% | 3.62% | +2.9% |
| Q2 2023 | $8,546,900 | -4.4% | 544,042 | +0.3% | 3.52% | -7.5% |
| Q1 2023 | $8,937,796 | +7.9% | 542,342 | +2.2% | 3.81% | +7.0% |
| Q4 2022 | $8,281,759 | +25.9% | 530,882 | +4.7% | 3.56% | +16.5% |
| Q3 2022 | $6,577,000 | -4.2% | 507,128 | +3.7% | 3.05% | +7.6% |
| Q2 2022 | $6,863,000 | +90.8% | 488,835 | +94.6% | 2.84% | +123.4% |
| Q1 2022 | $3,597,000 | +44862.5% | 251,220 | +67432.3% | 1.27% | +42233.3% |
| Q1 2019 | $8,000 | – | 372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 1,903,662 | $29,449,652 | 5.37% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,736,416 | $26,862,356 | 4.12% |
| Y.D. More Investments Ltd | 1,381,550 | $21,372,579 | 4.11% |
| Clean Yield Group | 533,157 | $8,167,965 | 3.62% |
| XY Capital Ltd | 143,697 | $2,222,993 | 1.28% |
| Mondrian Investment Partners LTD | 4,081,715 | $61,225,725 | 1.26% |
| Capricorn Fund Managers Ltd | 204,892 | $3,169,679 | 1.10% |
| Legacy Wealth Asset Management, LLC | 124,967 | $1,933,239 | 0.71% |
| HAP Trading, LLC | 263,679 | $4,079,114 | 0.65% |
| BRANDES INVESTMENT PARTNERS, LP | 1,802,036 | $27,877,493 | 0.54% |